课题基金 / 基金详情

Sequencing Core

Sequencing Core
测序核心
批准号:
10419452
负责人:
Gregory Seumois
金额:
$18.52万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-06-15 至 2027-05-31

项目摘要

项目成果

Gregory Seumois的其他基金

相似基金

相关文献

中文摘要
翻译
测序核心概述
英文摘要
Sequencing Core Summary The mission of the HIPC program at LJI is to use hypothesis-free approaches to define comprehensive molecular profiles of T cell subsets in the context of lung pathogens. The areas of interest cover an extremely wide spectrum of “omics” analysis including: (i) analysis of global gene expression (bulk and single-cell RNA-seq), (ii) analysis of T cell receptors high variable sequences repertoire by bulk or single-cell TCR-seq, (iii) analysis of changes in global epigenetics profiles (genome-wide enhancer profiles) using single-cell ATAC-seq, in T cell memory subsets from patients infected and/or vaccinated against, SARS-CoV-2, Mycobacterium tuberculosis (Mtb), and other lung pathogens. All these “omics” applications rely on standardized and well-validated high-throughput Next-Generation Sequencing (NGS) methods – a key service provided by this Core. The Sequencing Core will support all NGS activities for all the three projects involved in this program. This will be facilitated by the extensive genomics expertise of its personnel and the availability of cutting-edge technologies and automated platforms to generate highly reproducible and robust sequencing data from a large number of samples. Practically, the Sequencing Core will interface directly with all three Projects and provide a standardized and quality-controlled pipeline consisting of receiving samples, sorting cells, preparing RNA/DNA, preparing libraries for high-throughput NGS, and transferring the resulting data to the Data Management and Analysis Core for subsequent analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel CD4+ T cell subset associated with allergy protection
  • 批准号:
    10742709
  • 项目类别:
  • 资助金额:
    $27.45万
  • 财政年份:
    2023
  • 负责人:
    Gregory Seumois
  • 依托单位:
Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma
  • 批准号:
    10708060
  • 项目类别:
  • 资助金额:
    $45.75万
  • 财政年份:
    2022
  • 负责人:
    Gregory Seumois
  • 依托单位:
Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma
  • 批准号:
    10588108
  • 项目类别:
  • 资助金额:
    $45.75万
  • 财政年份:
    2022
  • 负责人:
    Gregory Seumois
  • 依托单位:
Sequencing and Epigenetics Core
  • 批准号:
    10578440
  • 项目类别:
  • 资助金额:
    $45.24万
  • 财政年份:
    2019
  • 负责人:
    Gregory Seumois
  • 依托单位:
国内基金
海外基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵 袭的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    柳静
  • 依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
  • 批准号:
    62302218
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    张双全
  • 依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子